Hodgkin's Treatment, Breast Cancer Linked, University of Florida Study 2/18/2009
More...
|
University of Southern California Researchers Find New Clues To Risk Of Hodgkin Lymphoma 4/2/2008
More...
|
Seattle Genetics, Inc. (SGEN) Expands SGN-35 Clinical Program with Initiation of Second Phase I Trial 3/28/2008
More...
|
Seattle Genetics, Inc. (SGEN) Reports Positive Phase I Data with SGN-35 in Hodgkin Lymphoma 11/5/2007
More...
|
Pharmion Corporation (PHRM) and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma 8/21/2007
More...
|
Chromosomes Tell Tale of Patient's Risk for New, Future Cancer 4/17/2007
More...
|
Hodgkin's Disease Therapy Ups Heart Attack Risk 2/7/2007
More...
|
Gemin X Biotechnologies Inc. Phase 1 Data Show Clinical Activity Of GX15-070 In Myelodysplastic Syndromes 12/11/2006
More...
|
Seattle Genetics, Inc. (SGEN) Initiates Phase I Clinical Trial Of SGN-35 11/17/2006
More...
|
Gemin X Biotechnologies Inc. Initiates Phase 2 Clinical Trial Program For GX15-070 In Myelofibrosis And Hodgkin's Lymphoma 9/14/2006
More...
|
MethylGene's HDAC Inhibitor, MGCD0103, Enters Phase II Clinical Trial In Patients With Refractory Or Relapsed Hodgkin's Lymphoma 8/22/2006
More...
|
First Patient Dosed In Phase 1 Trial Of Tanox, Inc. (TNOX)'s TNX-650 5/23/2006
More...
|
Genitope Corporation (GTOP) Signs Leases For New Commercial Manufacturing Facility And Corporate Headquarters 5/23/2005
More...
|
INEX Pharmaceuticals (IEX.TO) Presents Marqibo(TM) Clinical Data At Medical Meetings 5/18/2005
More...
|
Seattle Genetics, Inc. (SGEN) Provides Update On SGN-30 And SGN-40 Clinical Programs At American Society of Clinical Oncology 5/16/2005
More...
|
MorphoSys AG Generated Antibody Approved To Enter Clinical Trials 12/9/2004
More...
|
American Society of Hematology (ASH) Release: Modified Cancer Therapy Regimens Offer Successful Treatments For Lymphoma With Few Side Effects 12/6/2004
More...
|
AnorMED (AOM.TO) Evaluates New Stem Cell Transplantation Drug Candidate As Single Agent In Multiple Myeloma Patients And As Combination Regimen In Patients With Hodgkin's disease 12/1/2004
More...
|
Celgene Corporation (CELG) Release: 113 Abstracts On Recent Clinical Data For Thalomid(R), Revlimid(TM), Actimid(TM) And Alkeran(R) To Be Presented At The American Society of Hematology (ASH) 46th Annual Meeting 11/30/2004
More...
|
Medarex, Inc. (MEDX) Announces MDX-060 Receives Orphan Drug Designation For Treatment Of Hodgkin's Disease 10/6/2004
More...
|
Cancer Gene Controls Nerve Growth 9/3/2004
More...
|
Hodgkin's Therapy Tied To Later Heart Problems 8/12/2004
More...
|
First Woman Pregnant After Ovarian Transplant 6/30/2004
More...
|
Study: Virus Can Indicate Cancer's Aggressiveness 6/11/2004
More...
|
Medarex, Inc. (MEDX) Announces Promising Phase II Results With MDX-060 In Hodgkin's Disease 6/9/2004
More...
|
Medarex, Inc. (MEDX) Announces 2003 Fourth Quarter And Year-End Financial Results 2/27/2004
More...
|
Seattle Genetics, Inc. (SGEN) Receives Orphan Drug Designation For SGN-30 In T-Cell Lymphomas 2/26/2004
More...
|
Seattle Genetics, Inc. (SGEN) Advances SGN-30 To Phase II Clinical Study 1/22/2004
More...
|
Medarex, Inc. (MEDX) Announces Complete And Partial Responses Observed In Phase I/II Clinical Study Of MDX-060 At American Society of Hematology (ASH) Meeting 12/9/2003
More...
|
INEX Pharmaceuticals (CT:IEX) Releases Onco TCS Data From Three Clinical Trials At Annual Meeting Of American Society of Hematology (ASH) 12/8/2003
More...
|
Warning Over Cancer Therapy Risk 11/10/2003
More...
|
Medarex, Inc. (MEDX) Announces MDX-060 Presentation At The American Society Of Hematology Meeting 11/5/2003
More...
|